Can I Switch Hospitals Midway Through IVF in Thailand? Conditions and Risks Explained

AI Summary

Main Content Begins

Switching Hospitals Midway Through IVF in Thailand: Direct Answer

Switching hospitals midway through IVF in Thailand is technically possible, but in practice, there are strict limitations. Whether you can transfer, the cost involved, and the impact on your cycle depend on which treatment stage you are in, the policies of both hospitals, and the legal ownership of the embryos. Based on past cases, most transfers occur during the preparatory phase before the cycle starts. Once ovarian stimulation or embryo culture has begun, the difficulty of transferring increases significantly.

When is it Suitable to Transfer & When is it Unsuitable

Suitable Situations for Transfer

• The original hospital suddenly ceases operations or has a major medical dispute, making it impossible to continue treatment.
• The original hospital cannot provide the required technology, such as needing PGT but the center lacks the qualification, or needing specialized lab techniques (e.g., oocyte activation, time-lapse embryo imaging).
• The patient needs to change cities for significant personal reasons (e.g., job relocation, family emergency), and the new city has a suitable fertility center.
• You are in the preliminary examination stage, before filing a medical record or starting ovarian stimulation. Transferring at this stage has virtually no impact.

Unsuitable Situations for Transfer

• Ovarian stimulation has already started: The protocol is continuous. Changing doctors and labs midway creates transition risks that may affect the synchrony of follicle development.
• Embryos have formed after egg retrieval: Embryo transport carries the risk of temperature fluctuations in liquid nitrogen. Additionally, whether the new lab accepts external embryos and recognizes the original grading system are issues.
• The endometrium has already been transformed before transfer: Transferring at this point directly interrupts the transfer cycle, requiring the endometrium to be prepared again, costing time and money.
• Embryos have been sent for PGT testing: Transferring during testing may cause sample interruption and result incompatibility, requiring re-testing.

Why Transferring Carries Risks

The fundamental reason lies in the continuity and quality control of the assisted reproduction process. Each fertility center has different ovarian stimulation protocols, lab culture systems, embryo grading standards, and transfer strategies. Switching hospitals midway is like inserting an interface into a complete chain, and this interface is where problems are most likely to occur. Furthermore, embryos are legally considered biological materials under the joint supervision of the patient and the hospital. Transfer involves multiple issues such as ownership transfer, transport safety, and liability division. Many fertility centers in Thailand explicitly state in their treatment consent forms that "embryos from a cycle started at this center cannot be transferred out," a clause easily overlooked when signing the contract.

Table: Comparison of Transfer by Different Stages

Comparison of Transfer Feasibility at Different Treatment Stages

What is the Specific Transfer Process?

If a transfer is indeed necessary, the following steps are typically required. The overall process takes approximately 1–3 weeks, depending on the cooperation of both hospitals.

1. Submit a written transfer request to the original hospital, stating the reason for transfer and the receiving hospital's information.
2. Obtain complete medical records (including ovarian stimulation records, egg retrieval records, embryo grading, PGT reports, imaging data, etc.), usually requiring English or Thai translations.
3. Confirm the method of embryo/egg transport: liquid nitrogen tank transport (requires a professional company) or fresh transport (rare cases).
4. Contact the new hospital to confirm acceptance conditions: Does it accept external embryos? Is re-registration needed? Are additional tests required?
5. Sign the new hospital's informed consent form and complete registration.
6. Settle fees with the original hospital and process embryo release.
7. Complete the transport, and the new hospital receives and confirms the embryo status.

What Needs to Be Prepared

• Passport (validity must cover the entire treatment cycle and subsequent transfer plans; it is generally recommended to have at least 6 months remaining validity)
• Visa (based on the time required for transfer, confirm whether a visa extension or change of visa type is needed)
• Treatment records from the original hospital (originals + translations)
• Proof of embryo ownership (issued by the original hospital)
• Letter of acceptance from the new hospital
• Notarized marriage certificate (if joint embryos are involved)
• Documents required for registration: passport, visa, marriage certificate, previous examination reports, AMH, FSH, LH, antral follicle count, semen analysis, chromosome testing, genetic counseling report, uterine cavity examination report, etc.

Factors Influencing Costs

The costs incurred from transferring vary greatly depending on the hospital and specific circumstances. The following are reference ranges:

• Medical record retrieval and translation fee: 1,000–4,000 Thai Baht
• Embryo transport fee (including liquid nitrogen tank rental, professional transport): 5,000–20,000 Thai Baht
• New hospital registration fee: 3,000–8,000 Thai Baht
• Re-testing fee (e.g., infectious disease screening, chromosome karyotype, AMH): 10,000–35,000 Thai Baht
• Legal fee (if embryo ownership disputes arise): 5,000–20,000 Thai Baht
• Additional accommodation and transportation: depends on the length of stay

Easily Overlooked Details

• Embryo ownership in contract terms: Many hospitals include clauses in the treatment consent form stating "embryos cannot be transferred out" or "transfer requires additional fees," which are easily overlooked when signing.
• Differences in embryo grading systems: Different labs use different grading standards for embryo quality. A "good quality embryo" at Hospital A might be considered transferable but not optimal at Hospital B, affecting subsequent decisions.
• Coordination of ovarian stimulation protocols: Is the new hospital familiar with the protocol used by the original hospital (e.g., long protocol, antagonist protocol, PPOS protocol)? Poor coordination may affect follicle development.
• Differences in luteal phase support protocols: Post-transfer luteal phase support medications (oral, vaginal gel, injections, etc.) vary by hospital habit and need to be reconfirmed after transfer.
• Psychological cost: The uncertainty, waiting time, and communication effort involved in transferring can significantly impact a patient's mental state.

Differences Between Hospitals

Policies regarding "accepting external embryos" vary significantly among fertility centers in Thailand. Some hospitals explicitly do not accept them, others accept them but charge extra, and some only accept embryos at specific stages. Additionally, the laboratory's hardware level (e.g., time-lapse imaging system, air filtration grade, liquid nitrogen storage monitoring) can affect the survival rate of embryos after transport. It is advisable to have the new hospital assess the feasibility of embryo transport before deciding to transfer, rather than starting the paperwork first and then evaluating.

From a reproductive doctor's perspective, the doctor will focus on whether the patient's basic indicators such as AMH, FSH, LH, and antral follicle count support adjusting the protocol, and whether semen analysis, chromosome testing, and genetic counseling reports are complete. If the patient is older (≥38 years) or has low ovarian reserve (AMH < 1.2 ng/mL), doctors generally do not recommend transfer because every egg is precious, and the transport risk may not be worth taking.

Handling Special Situations

• Original hospital ceases operations: Immediately contact the Thai Assisted Reproduction Association or relevant regulatory authorities to obtain medical records and embryos. There is usually an official coordination process, but it can be time-consuming.
• Medical dispute: Until the dispute is resolved, the hospital may freeze medical records and embryos. In this case, transfer requires legal intervention, and it is advisable to consult local medical legal professionals.
• Need for special technology: If the original hospital cannot provide PGT, oocyte activation, endometrial receptivity testing (ERA), etc., but the new hospital can, the reason for transfer is valid, but the feasibility of embryo transport must be assessed.
• Patients with low AMH: If AMH is below 0.8 ng/mL and ovarian reserve is limited, it is essential to confirm before transfer that the new hospital has experience handling low-reserve patients and that the transport plan minimizes the risk of embryo loss.

Risk Reminder End